Expression of p53 protein in T- and natural killer-cell lymphomas is associated with some clinicopathologic entities but rarely related to p53 mutations

Human Pathology

Volumn 32, Issue 2, 2001, Pages 196-204

  Petit, Barbara ^a,b,c   Leroy, Karen ^a,b,c   Kanavaros, Panagiotis ^a,b,c   Boulland, Marie Laure ^a,b,c   Druet Cabanac, Michel ^a,b,c   Haioun, Corinne ^a,b,c   Bordessoule, Dominique ^a,b,c   Gaulard, Philippe ^a,b,c  

^a Hôpital Henri Mondor   (Greece)

^b DUPUYTREN UNIVERSITY HOSPITAL   (France)

^c UNIVERSITY OF THESSALY   (Greece)

Author keywords

Epstein Barr virus; Natural killer cell lymphoma; P21; P53; T cell

Indexed keywords

PROTEIN P21; PROTEIN P53;

ADULT; AGED; ARTICLE; FEMALE; GENE OVEREXPRESSION; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOPHENOTYPING; LYMPHOMA; MAJOR CLINICAL STUDY; MALE; NATURAL KILLER CELL; PROTEIN EXPRESSION; T CELL LYMPHOMA;

EID: 0035127864     PISSN: 00468177     EISSN: None     Source Type: Journal    
DOI: 10.1053/hupa.2001.21569     Document Type: Article

References (40)

1. A revised European-American classification of lymphoid neoplasms. A proposal from the International Lymphoma Study Group
2. Prognostic significance of T-cell phenotype in aggressive non-Hodgkin's lymphomas. Groupe d'Etude des Lymphomes de l'Adulte (GELA)
3. The Non-Hodgkin's Lymphoma Classification Project: A clinical evaluation of the International Lymphoma Study Group classification of non-Hodgkin's lymphoma
4. Multiple pathways control cell growth and transformation: Overlapping and independent activities of p53 and p21
5. The p53 pathway
6. WAF1, a potential mediator of p53 tumor suppression
7. Mutations in p53 produce a common conformational effect that can be detected with a panel of monoclonal antibodies directed toward the central part of the p53 protein
8. P53 in hematologic malignancies
9. P53 mutations in human lymphoid malignancies: Association with Burkitt lymphoma and chronic lymphocytic leukemia
10. P21/WAF1 cyclin-kinase inhibitor expression in non-Hodgkin's lymphomas: A potential marker of p53 tumor-suppressor gene function
11. WAF1/CIP1 and mdm2 expression in non-Hodgkin's lymphoma and their relationship to p53 status: A p53+, mdm2-, p21- immunophenotype associated with missense p53 mutations
12. Mutations of the p53 gene as a pronostic factor in aggressive B-cell lymphoma
13. Correlation between mutation in P53, p53 expression, cytogenetics, histologic type, and survival in patients with B-cell non-Hodgkin's lymphoma
14. The accumulation of p53 abnormality is associated with progression of mucosa-associated lymphoid tissue lymphoma
15. p53 Gene mutations and protein overexpression are associated with variants of mantle cell lymphomas
16. p53 Mutation is associated with progression in follicular lymphomas
17. Expression of p53 and retinoblastoma gene expression in high-grade nodal peripheral T-cell lymphomas: Immunohistochemical and molecular findings suggesting different pathogenetic pathways and possible clinical implications
18. Post-thymic T cell lymphomas frequently overexpress p53 protein but infrequently exhibit p53 gene mutations
19. The World Health Organization classification of neoplastic diseases of the hematopoietic and lymphoid tissues
20. Nasal T-cell lymphoma: A clinicopathologic entity associated with peculiar phenotype and with Epstein-Barr virus
21. Immunoenzymatic labelling of monoclonal antibodies using immune complexe of alkaline phosphate and monoclonal antialkaline phosphatase (APAAP complexes)
22. A novel, simple, reliable, and sensitive method for multiple immunoenzyme staining: Use of microwave oven heating to block antibody cross-reactivity and retrieve antigens
23. Primary brain lymphoma cell turnover differs in patients with and without AIDS: Relationships to bcl-2 expression and host cell reaction
24. Efficient screening of p53 mutations by denaturing gradient gel electrophoresis in colorectal tumors
25. High levels of p53 protein expression do not correlate with p53 gene mutations in anaplastic large cell lymphoma
26. + anaplastic large-cell lymphoma. High frequency of c-myc proto-oncogene activation
27. Histological and immunophenotypic profile of nasal NK/T-cell lymphomas from Peru: High prevalence of p53 overexpression
28. p53 Mutations in human cancers
29. Mutations in the p53 gene are not limited to classic 'hot spots' and are not predictive of p53 protein expression in high-grade non-Hodgkin's lymphoma
30. Human non-Hodgkin's lymphomas overexpress a wild-type form of p53 which is a functional transcriptional activator of the cyclin-dependent kinase inhibitor p21
31. A p161NK4a-insensitive CDK4 mutant targeted by cytolytic T lymphocytes in a human melanoma
32. Large E1B proteins of adenovirus types 5 and 12 have different effects on p53 and distinct roles in cell transformation
33. Signaling to p53: Breaking the mdm2-p53 circuit
34. Why is p53 protein stabilized in neoplasia? Some answers but many more questions
35. EBNA-5, an Epstein-Barr virus-encoded nuclear antigen, binds to the retinoblastoma and p 53 proteins
36. Viral genotypes and p53 expression in Epstein-Barr virus associated primary malignant lymphomas of the intestines
37. Epstein-Barr virus nuclear antigen 2 and latent membrane protein independently transactivate p53 through induction of NF-kappaB activity
38. Positive correlation between apoptotic and proliferative indices in gastrointestinal lymphoma of mucosa-associated lymphoid tissue
39. Prognostic significance of proliferative and apoptotic fractions in low grade follicle center-derived non-Hodgkin's lymphomas